Home LiteratureArticle Details
PMID: 2858824 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons.

Naunyn-Schmiedeberg's archives of pharmacology ·Vol. 328 ·No. 3 ·1985-01-00 ·Pages 331-40

Lundberg JM, Saria A, Franco-Cereceda A, Hökfelt T, Terenius L, Goldstein M

Abstract

The effects of 6-hydroxydopamine (6-OHDA) and reserpine pretreatment on peripheral neuropeptide Y (NPY)- and noradrenaline (NA)-containing neurons were studied in guinea-pigs. Ten days after 6-OHDA pretreatment, a 60-80% reduction of the NA content was observed in the right atrium of the heart, stellate ganglion and spleen. The content of NPY-like immunoreactivity (LI) was reduced by about 50% in the heart, not changed in the spleen while it increased to 200% of control in the stellate ganglion. Immunohistochemistry showed a pronounced loss of NPY- and tyrosinehydroxylase (TH)-immunoreactive (IR) nerves in the heart but not in the spleen. Increased NPY-IR was seen in axons and cell bodies of the stellate ganglion. Reserpine pretreatment (thereshold dose 0.5 mg X kg-1) caused a dose- and time-dependent reduction of the content of NPY-LI in the heart. A maximal depletion of NPY-LI (about 80%) was observed 5 days after reserpine. Reserpine pretreatment also reduced the content of NPY-LI in the spleen, while no significant change was observed in the adrenal gland or vas deferens. The levels of NPY-LI increased in the stellate ganglion to about 180% of control 5 days after reserpine. Immunohistochemical analysis revealed an almost total loss of NPY-IR nerve fibres in the heart as well as around blood vessels in the lung and skeletal muscle. No detectable changes were observed in perivascular NPY-IR nerves in the spleen, vas deferens or kidney. TH-IR nerves remained unchanged after reserpine, thus indicating that the observed loss of NPY-IR nerves was due to a depletion of NPY and not a degeneration. No change in the levels of substance P-LI was observed in the right atrium 5 days after reserpine. NA was, in contrast to NPY, markedly depleted in all tissues investigated after reserpine treatment. The depletion of NA was more extensive, and occurred more rapidly and at much lower doses as compared to the effects on NPY-LI. Ligations of the sciatic nerve revealed that NPY-LI was transported axonally with a rapid rate (3 mm/h). Reserpine pretreatment significantly increased the amount of accumulated NPY-IR above the ligation, suggesting an increase in axonal transport. High performance liquid chromatography revealed that the NPY-LI consisted of two major peaks in the stellate ganglia, while only one peak closely corresponding to porcine NPY was seen in the right atrium. In conclusion, 6-OHDA pretreatment depletes NPY-LI in certain terminal regions and increases NPY-LI in ganglia.(ABSTRACT TRUNCATED AT 400 WORDS)

MeSH Terms
Animals Ganglia, Sympathetic/analysis Guinea Pigs Hydroxydopamines/pharmacology Male Myocardium/analysis Nerve Tissue Proteins/analysis Neurons/analysis,drug effects Neuropeptide Y Norepinephrine/analysis Oxidopamine Reserpine/pharmacology Spleen/analysis Tyrosine 3-Monooxygenase/analysis Vas Deferens/analysis
Chemicals
Hydroxydopamines Nerve Tissue Proteins Neuropeptide Y Reserpine Oxidopamine Tyrosine 3-Monooxygenase Norepinephrine
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Lundberg J M
Saria A
Franco-Cereceda A
Hökfelt T
Terenius L
Goldstein M
References (29)
29 references, click to expand
  1. Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line.
    Mol Pharmacol. 1980 Jan;17(1):79-85 PMID: 6104286
  2. Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade.
    Acta Physiol Scand. 1982 Dec;116(4):393-402 PMID: 6133408
  3. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function.
    Acta Physiol Scand. 1982 Dec;116(4):477-80 PMID: 6763452
  4. Are opioid peptides co-transmitters in noradrenergic vesicles of sympathetic nerves?
    Nature. 1980 Dec 25;288(5792):707-9 PMID: 6109254
  5. Distribution, pathways and reactions to drug treatment of nerves with neuropeptide Y- and pancreatic polypeptide-like immunoreactivity in the guinea-pig digestive tract.
    Cell Tissue Res. 1983;234(1):71-92 PMID: 6416674
  6. Evidence for coexistence of vasoactive intestinal polypeptide (VIP) and acetylcholine in neurons of cat exocrine glands. Morphological, biochemical and functional studies.
    Acta Physiol Scand Suppl. 1981;496:1-57 PMID: 7030007
  7. Small noradrenergic storage vesicles isolated from rat vas deferens--biochemical and morphological characterization.
    Acta Physiol Scand Suppl. 1980;493:1-28 PMID: 6941628
  8. Localization of vasoactive intestinal polypeptide- and avian pancreatic polypeptide-like immunoreactivity in the Golgi apparatus of peripheral neurons.
    Brain Res. 1983 Feb 28;262(1):71-8 PMID: 6131731
  9. Increased tyrosine hydroxylase activity after drug-induced alteration of sympathetic transmission.
    Nature. 1969 Mar 29;221(5187):1264 PMID: 4304400
  10. Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin.
    Br J Pharmacol. 1980 Feb;68(2):207-13 PMID: 6153545
  11. Comparative immunohistochemical and biochemical analysis of pancreatic polypeptide-like peptides with special reference to presence of neuropeptide Y in central and peripheral neurons.
    J Neurosci. 1984 Sep;4(9):2376-86 PMID: 6548255
  12. Coexistence of an avian pancreatic polypeptide (APP) immunoreactive substance and catecholamine in some peripheral and central neurons.
    Acta Physiol Scand. 1980 Sep;110(1):107-9 PMID: 6162364
  13. Neuropeptide Y (NPY) depresses the secretion of 3H-noradrenaline and the contractile response evoked by field stimulation, in rat vas deferens.
    Acta Physiol Scand. 1984 Mar;120(3):477-9 PMID: 6547562
  14. The effects of 5-hydroxytryptamine-depleting drugs on peptides in the ventral spinal cord.
    Eur J Pharmacol. 1981 Dec 3;76(2-3):203-10 PMID: 6174352
  15. Determination of norepinephrine and its metabolites released from rat vas deferens using high-performance liquid chromatography with electrochemical detection.
    Life Sci. 1983 Feb 28;32(9):933-40 PMID: 6827923
  16. The storage of endogenous noradrenaline in sympathetic nerve terminals.
    J Physiol. 1971 May;215(1):163-79 PMID: 5579649
  17. Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system.
    Neuroscience. 1978;3(6):517-38 PMID: 358011
  18. The recovery of the capacity for uptake-retention of ( 3 H)noradrenaline in rat adrenergic nerves after reserpine.
    J Pharm Pharmacol. 1972 Jul;24(7):565-74 PMID: 4116402
  19. Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically stimulated mouse vas deferens.
    Neuropeptides. 1982 Dec;3(2):71-7 PMID: 6186938
  20. Substance P-like immunoreactivity in nerves associated with the vascular system of guinea-pigs.
    Neuroscience. 1982 Feb;7(2):447-59 PMID: 6176910
  21. Neuropeptide Y: complete amino acid sequence of the brain peptide.
    Proc Natl Acad Sci U S A. 1982 Sep;79(18):5485-9 PMID: 6957876
  22. Mechanism of secretion from the adrenal medulla. IV. The fate of the storage vesicles following insulin and reserpine administration.
    Mol Pharmacol. 1969 Jan;5(1):69-82 PMID: 5373889
  23. Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1968;261(3):271-88 PMID: 4387076
  24. Tissue and plasma catecholamines and dopamine beta-hydroxylase activity of various animal species after neurogenic sympathetic stimulation.
    J Physiol. 1978 Dec;285:515-29 PMID: 745119
  25. Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig.
    Acta Physiol Scand. 1984 Aug;121(4):325-32 PMID: 6091417
  26. High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man.
    Neurosci Lett. 1983 Dec 2;42(2):167-72 PMID: 6689363
  27. Synthesis of enkephalins by adrenal medullary chromaffin cells: reserpine increases incorporation of radiolabeled amino acids.
    Proc Natl Acad Sci U S A. 1980 Jul;77(7):4364-8 PMID: 6933489
  28. Neuropeptide Y in phaeochromocytomas and ganglioneuroblastomas.
    Lancet. 1983 Sep 3;2(8349):540-2 PMID: 6136694
  29. Evidence for the presence of enkephalins in the heart.
    Life Sci. 1983 Jan 24;32(4):399-406 PMID: 6827901
Article Info
Journal
Naunyn-Schmiedeberg's archives of pharmacology
Abbr.
Naunyn Schmiedebergs Arch Pharmacol
ISSN
0028-1298
Published
1985-01-00
Pages
331-40
Language
English
Region
Germany
NLM ID
0326264
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com